Gerst Diane G.
Director at AMPH
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Jul 18, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AMPHAmphastar Pharmaceuticals, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AMPHPlan not statedNov 21, 2017 2017
Sold 523 shares at $18.81 ($10k)
Gerst Diane G., EVP, QA & Regulatory Affairs
Sold 1.6% of holdings ($607k position)31,733 shares left0.4x usual sizeFiling
- 2 Form 4 sale AMPHPlan not statedNov 28, 2017 +7 days
Sold 523 shares at $18.15 ($9k)
Gerst Diane G., EVP, QA & Regulatory Affairs
Sold 1.6% of holdings ($576k position)31,210 shares left0.5x usual sizeFiling
- 3 Form 4 sale AMPHPlan not statedDec 12, 2017 +14 days
Sold 523 shares at $18.96 ($10k)
Gerst Diane G., EVP, QA & Regulatory Affairs
Sold 1.7% of holdings ($592k position)30,687 shares left1x usual sizeFiling
- 4 Form 4 sale AMPHPlan not statedDec 19, 2017 +7 days
Sold 523 shares at $19.48 ($10k)
Gerst Diane G., EVP, QA & Regulatory Affairs
Sold 1.7% of holdings ($598k position)30,164 shares left1x usual sizeFiling
- 5 Form 4 sale AMPHUnusualJun 30, 2022 +1654 days
Sold 5,146 shares at $35.00 ($180k)
Gerst Diane G., Director
Sold 28.6% of holdings ($630k position)12,842 shares leftFirst sale on recordFiling
- 6 Form 4 sale AMPHPlan not statedJul 5, 2022 +5 days
Sold 1,813 shares at $35.00 ($63k)
Gerst Diane G., Director
Sold 12.4% of holdings ($513k position)12,842 shares leftFiling
- 7 Form 4 sale AMPHPlan not statedJul 11, 2022 +6 days
Sold 1,521 shares at $36.26 ($55k)
Gerst Diane G., Director
Sold 10.6% of holdings ($521k position)12,842 shares leftFiling
- 8 Form 4 sale AMPHPlan not statedJul 18, 2022 +7 days
Sold 1,520 shares at $37.23 ($57k)
Gerst Diane G., Director
Sold 10.6% of holdings ($535k position)12,842 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 | Jul 19, 2022 | AMPH | Director | Form 4 sale | 1,520 | $57k | 10.6% | Plan not stated | SEC |
| Jul 11, 2022 | Jul 12, 2022 | AMPH | Director | Form 4 sale | 1,521 | $55k | 10.6% | Plan not stated | SEC |
| Jul 5, 2022 | Jul 6, 2022 | AMPH | Director | Form 4 sale | 1,813 | $63k | 12.4% | Plan not stated | SEC |
| Jun 30, 2022 | Jul 5, 2022 | AMPH | Director | Form 4 sale | 5,146 | $180k | 28.6% | Unusual | SEC |
| Dec 19, 2017 | Dec 19, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $10k | 1.7% | Plan not stated | SEC |
| Dec 12, 2017 | Dec 14, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $10k | 1.7% | Plan not stated | SEC |
| Nov 28, 2017 | Nov 30, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $9k | 1.6% | Plan not stated | SEC |
| Nov 21, 2017 | Nov 21, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $10k | 1.6% | Plan not stated | SEC |
| Nov 15, 2017 | Nov 17, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $9k | 1.6% | Plan not stated | SEC |
| Nov 7, 2017 | Nov 9, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $9k | 1.6% | Plan not stated | SEC |
| Oct 24, 2017 | Oct 26, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $10k | 1.5% | Plan not stated | SEC |
| Oct 17, 2017 | Oct 19, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 523 | $10k | 1.5% | Plan not stated | SEC |
| Oct 5, 2017 | Oct 6, 2017 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 8,444 | $159k | 19.7% | Plan not stated | SEC |
| Dec 15, 2016 | Dec 16, 2016 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 2,940 | $60k | 10.1% | Plan not stated | SEC |
| Aug 19, 2016 | Aug 19, 2016 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 24,046 | $464k | 45.3% | Unusual | SEC |
| May 18, 2016 | May 19, 2016 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 1,427 | $20k | 4.7% | Plan not stated | SEC |
| Apr 19, 2016 | Apr 20, 2016 | AMPH | EVP, QA & Regulatory Affairs | Form 4 sale | 21,244 | $274k | 41.4% | Unusual | SEC |
| Apr 8, 2015 | Apr 10, 2015 | AMPH | Corp. SVP of Quality Assurance | Form 4 sale | 10,000 | $158k | 33.9% | Unusual | SEC |